Please assess the completion status of the following clinical trial:

Trial Title: Fascia Iliaca Block for Post-Operative Pain Control After Total Hip Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* anterior approach total hip arthroplasty (THA) for unilateral osteoarthritis~* English-speaking~* age 18 to 75 years~* American Society of Anesthesiologists (ASA) physical status 1 to 3~* BMI \< 40 kg/m2~* Minimum weight of 50 kg.~* No contraindications to study procedures~Exclusion Criteria:~* Hip revision surgery~* Allergy to local anesthetics~* Allergy to oxycontin~* Allergy to pregabalin~* Allergy to fentanyl~* Allergy to midazolam~* Allergy to hydromorphone~* BMI \> 40 kg/m2~* Chronic pre-operative opioid use

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- ropivacaine block (Type: ACTIVE_COMPARATOR): Ropivacaine 0.375% as a one-time 60 milliliter injection.
- saline block (Type: PLACEBO_COMPARATOR): Sodium chloride 0.9% as a one-time 60 milliliter injection.

Based on this trial design, predict the completion outcome and termination type (if applicable).